Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Ball

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
JAAD Case Reports|April 13, 2019
Pediatric erythromelalgia treated with epidural ropivacaine infusionCaroline E Lee, Kelly Paulk, Kristen Garvie, et al.
The American Journal of Sports Medicine|March 18, 2016
Fastball Pitch Velocity Helps Predict Ulnar Collateral Ligament Reconstruction in Major League Baseball PitchersPeter N Chalmers, Brandon J Erickson, Brian Ball, et al.
Blood Cancer Journal|November 28, 2023
Correction: TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Blood Cancer Journal|October 4, 2022
TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 20, 2025
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experienceJose Tinajero, Dat Ngo, Brian Lee, et al.
Leukemia & Lymphoma|January 2, 2024
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinibDat Ngo, Jose Tinajero, Shanpeng Li, et al.
Molecular Cancer|March 30, 2023
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphomaElana Thieme, Nur Bruss, Duanchen Sun, et al.
Blood Advances|August 19, 2018
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemiaBrian Ball, Rami S Komrokji, Lionel Adès, et al.
American Journal of Hematology|January 3, 2023
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxisCorinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
JAAD Case Reports|April 13, 2019
Pediatric erythromelalgia treated with epidural ropivacaine infusionCaroline E Lee, Kelly Paulk, Kristen Garvie, et al.
The American Journal of Sports Medicine|March 18, 2016
Fastball Pitch Velocity Helps Predict Ulnar Collateral Ligament Reconstruction in Major League Baseball PitchersPeter N Chalmers, Brandon J Erickson, Brian Ball, et al.
Blood Cancer Journal|November 28, 2023
Correction: TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Blood Cancer Journal|October 4, 2022
TET2 deficiency promotes MDS-associated leukemogenesisFeiteng Huang, Jie Sun, Wei Chen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 20, 2025
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experienceJose Tinajero, Dat Ngo, Brian Lee, et al.
Leukemia & Lymphoma|January 2, 2024
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinibDat Ngo, Jose Tinajero, Shanpeng Li, et al.
Molecular Cancer|March 30, 2023
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphomaElana Thieme, Nur Bruss, Duanchen Sun, et al.
Blood Advances|August 19, 2018
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemiaBrian Ball, Rami S Komrokji, Lionel Adès, et al.
American Journal of Hematology|January 3, 2023
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxisCorinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
Blood|August 30, 2011
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndromeMadhu S Kumar, Anupama Narla, Atsushi Nonami, et al.
Pageof 6